{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:22:20Z","timestamp":1785435740432,"version":"3.56.0"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"SNUBH Research Fund","award":["16-2023-0011"],"award-info":[{"award-number":["16-2023-0011"]}]},{"name":"Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education","award":["RS-2025-00553721"],"award-info":[{"award-number":["RS-2025-00553721"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2026,6,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Treatment of nontuberculous mycobacteria (NTM) diseases, especially\n                      <jats:italic toggle=\"yes\">Mycobacterium abscessus<\/jats:italic>\n                      pulmonary disease, remains a major clinical challenge due to its broad antibiotic resistance and limited therapeutic options. To search for new candidates, we established a synthetic flavonoid library and screened it using a bioluminescent\n                      <jats:italic toggle=\"yes\">M. abscessus<\/jats:italic>\n                      reporter strain. Among the compounds tested, 6-methylflavone (6-MF) was identified as a selective inhibitor of mycobacterial growth. 6-MF showed consistent activity against multiple clinical isolates of\n                      <jats:italic toggle=\"yes\">M. abscessus<\/jats:italic>\n                      with minimum inhibitory concentration (MIC) values of 8\u201316 \u03bcg\/mL and was also effective against intracellular mycobacteria without cytotoxicity. The antimicrobial activity was largely restricted to mycobacteria, indicating its narrow spectrum. Checkerboard assays demonstrated strong synergy with clarithromycin, while the effect with amikacin was limited to weak synergy or indifference. Resistance to 6-MF emerged at a much lower frequency than to amikacin in vitro, underlining its clinical advantage. Notably, 6-MF increased mycobacterial respiratory flux and reduced membrane potential, phenotypes associated with disruption of membrane energetics. In a mouse model of pulmonary infection, 6-MF reduced bacterial burden and lung inflammation to a level comparable to amikacin. These results indicate that 6-MF is a promising lead compound with the potential for further development as a therapeutic option for\n                      <jats:italic toggle=\"yes\">M. abscessus<\/jats:italic>\n                      infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>\n                      Despite the increasing global incidence of nontuberculous mycobacterial (NTM) diseases, effective treatment regimens remain limited. In particular,\n                      <jats:italic toggle=\"yes\">Mycobacterium abscessus<\/jats:italic>\n                      exhibits notoriously multidrug resistance, making its treatment extremely challenging. In this study, we identified 6-methylflavone (6-MF) as a selective antimycobacterial compound through screening of synthetic flavonoid library. 6-MF specifically inhibited mycobacterial growth and disrupted membrane energetics while showing negligible effects on other bacterial genera. Mycobacteria have unique energy metabolic systems distinct to other bacteria and have been reported to be particularly susceptible to energy metabolism disruptors, such as bedaquiline, clofazimine, and telacebec (Q203). We hope this research will inspire further studies aimed at developing novel antimycobacterial strategies based on energetics disruption.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.03588-25","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:01:19Z","timestamp":1776690079000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["6-methylflavone exerts selective antimycobacterial activity with membrane energetics disruption and demonstrates therapeutic potential against\n                    <i>Mycobacterium abscessus<\/i>\n                    infection"],"prefix":"10.1128","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8659-8636","authenticated-orcid":true,"given":"Jaehun","family":"Oh","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, College of Medicine, Seoul National University","place":["Seoul, Republic of Korea"]},{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biomedical Sciences, College of Medicine, Seoul National University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Won","family":"Shin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01zqcg218","id-type":"ROR","asserted-by":"publisher"}],"name":"College of Pharmacy, Kyung Hee University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejun","family":"Seo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, College of Medicine, Seoul National University","place":["Seoul, Republic of Korea"]},{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Research Institute, College of Medicine, Seoul National University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1984-8864","authenticated-orcid":false,"given":"Hyung-Jun","family":"Kim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00cb3km46","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital","place":["Seongnam, South Korea"]},{"name":"Department of Internal Medicine, Seoul National University College of Medicine","place":["Seoul, South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-5470","authenticated-orcid":false,"given":"Nam-Jung","family":"Kim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01zqcg218","id-type":"ROR","asserted-by":"publisher"}],"name":"College of Pharmacy, Kyung Hee University","place":["Seoul, Republic of Korea"]},{"id":[{"id":"https:\/\/ror.org\/01zqcg218","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University","place":["Seoul, South Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0085-6709","authenticated-orcid":true,"given":"Bum-Joon","family":"Kim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Microbiology and Immunology, College of Medicine, Seoul National University","place":["Seoul, Republic of Korea"]},{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biomedical Sciences, College of Medicine, Seoul National University","place":["Seoul, Republic of Korea"]},{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Research Institute, College of Medicine, Seoul National University","place":["Seoul, Republic of Korea"]},{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical Research Center, Institute of Endemic Diseases, Seoul National University","place":["Seoul, Republic of Korea"]},{"id":[{"id":"https:\/\/ror.org\/01x8c0495","id-type":"ROR","asserted-by":"publisher"}],"name":"Wide River Institute of Immunology, Seoul National University","place":["Hongcheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2023.100408"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010007"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1394220"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/biology10020096"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01991-2018"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2005.01.013"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-013-0324-x"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092901"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020457"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90035-7"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27041149"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-022-00009-1"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00719-25"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0924-8579(02)00022-5"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/516284"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(20)30282-8"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3200"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.724725"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14070728"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00915"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae380"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.926361"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00535-2020"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100110"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbusres.2019.12.021"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.60.4.575-608.1996"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02293-13"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.6b00111"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt3159"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02295-24"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00236-20"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.120.000071"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2299(199706)41:2<99::AID-DDR7>3.0.CO;2-M"},{"key":"e_1_3_5_36_2","first-page":"1210","article-title":"Anti-microbial activity of substituted flavones against Escherichia coli and Propionibacterium acne","volume":"6","author":"Saryre SL","year":"2017","unstructured":"Saryre SL, Raghuwanshi PB. 2017. Anti-microbial activity of substituted flavones against Escherichia coli and Propionibacterium acne. J Appl Chem 6:1210\u20131214.","journal-title":"J Appl Chem"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184885"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1039\/C7MD00528H"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.03.057"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.joc.9b01162"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejoc.202001425"},{"key":"e_1_3_5_42_2","volume-title":"Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2011","unstructured":"Clinical and Laboratory Standards Institute. 2011. CLSI document M24-A2. In Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"2"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.9.2982-2989.2002"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006752"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.03588-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.03588-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:08:30Z","timestamp":1781701710000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.03588-25"}},"subtitle":[],"editor":[{"given":"Prabagaran","family":"Narayanasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,2]]}},"alternative-id":["10.1128\/spectrum.03588-25"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.03588-25","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"2025-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e03588-25"}}